Results: 44

Protein expression profiles and clinicopathologic characteristics associate with gastric cancer survival

Biol. Res; 52 (), 2019
BACKGROUND: Prognosis remains one of most crucial determinants of gastric cancer (GC) treatment, but current methods do not predict prognosis accurately. Identification of additional biomarkers is urgently required to identify patients at risk of poor prognoses. METHODS: Tissue microarrays were used to m...

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer

Biol. Res; 52 (), 2019
BACKGROUND: Epidermal growth factor receptor family members such as ErbB1 and ErbB3 are involved in tumor progression and metastasis. Although, there are various reports about the prognostic value of EGFR members separately in gastric cancer, there is not any report about the probable correlation between...

Câncer gástrico em adultos jovens: um grupo de pior prognóstico?

Rev. Col. Bras. Cir; 46 (4), 2019
RESUMO Objetivo: avaliar as características clínico-patológicas e sobrevivência de pacientes jovens, portadores de câncer gástrico, independentemente da intenção de tratamento. Métodos: análise retrospectiva de todos os pacientes com câncer gástrico submetidos a qualquer tratamento cirúrgi...

Conversion therapy for gastric cancer: expanding the treatment possibilities

ABCD (São Paulo, Impr.); 32 (2), 2019
ABSTRACT Background: Conversion therapy in gastric cancer (GC) is defined as the use of chemotherapy/radiotherapy followed by surgical resection with curative intent of a tumor that was prior considered unresectable or oncologically incurable. Aim: To evaluate the results of conversion therapy in the...

Introduction of the new lymphoparietal index for gastric cancer patients

ABCD (São Paulo, Impr.); 32 (2), 2019
ABSTRACT Background: The identification of prognostic factors of gastric cancer (GC) has allowed to predict the evolution of patients. Aim: Assess the reliability of the lymphoparietal index in the prediction of long-term survival in GC treated with curative intent. Method: Prospective study of the ...

Survival and perioperative morbidity of totally laparoscopic versus open gastrectomy for early gastric cancer: analysis from a single latin american centre

ABCD (São Paulo, Impr.); 32 (1), 2019
ABSTRACT Background: Laparoscopic gastrectomy has numerous perioperative advantages, but the long-term survival of patients after this procedure has been less studied. Aim: To compare survival, oncologic and perioperative outcomes between completely laparoscopic vs. open gastrectomy for early gastric c...

Cáncer gástrico: algunas consideraciones sobre factores de riesgo y Helicobacter pylori
Gastric cancer: some considerations on risk factors and Helicobacter

Rev. medica electron; 40 (2), 2018
RESUMEN La Organización Mundial de la Salud señala que el cáncer gástrico es una neoplasia frecuente en el mundo contemporáneo. Constituye la segunda causa de muerte en el hombre y la tercera en las mujeres. Numerosos son los factores de riesgo que se asocian con la aparición del cáncer gástrico,...

Surgical treatment of gastric cancer: a 10-year experience in a high-volume university hospital

Clinics; 73 (supl.1), 2018
OBJECTIVES: Surgery remains the cornerstone treatment modality for gastric cancer, the fifth most common type of tumor in Brazil. The aim of this study was to analyze the surgical treatment outcomes of patients with gastric cancer who were referred to a high-volume university hospital. METHODS: We revie...

Factores pronósticos de sobrevida alejada en cáncer gástrico: introducción del nuevo índice N+/T

Rev. chil. cir; 70 (2), 2018
Resumen Introducción: La identificación de factores pronósticos del cáncer gástrico, ha permitido predecir la evolución de los pacientes y así tomar decisiones terapéuticas. En Chile existe un déficit en el análisis de factores pronósticos de sobrevida alejada. Objetivos: Los objetivos de es...

Rankl expression predicts poor prognosis in gastric cancer patients: results from a retrospective and single-center analysis

Braz. j. med. biol. res; 51 (3), 2018
The receptor activator of nuclear factor κB ligand (RANKL)/RANK pathway plays an important role in the prognosis of several solid tumor types, but its role in gastric cancer prognosis has been poorly characterized. A total of 116 gastric cancer patients who underwent surgical resection were enrolled...